This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

SEN78702

Siena Biotech S.p.A.

Drug Names(s): WYE-308775

Description: SEN12333 is an alpha 7 nicotinic acetylcholine receptor agonist.

Deal Structure: In October 2004, Sienabiotech announced that they entered into an agreement with Wyeth Pharmaceuticals to perform joint research and co-develop compounds targeted towards treatment of neurodegenerative diseases. The undisclosed financial terms of the partnership have been established to yield long term value to each partner.

Per a Pfizer representative, this compound was not included in Pfizer's acquisition of Wyeth in October 2009.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug